Factor | Lugsomya2018 (20009)

10.1089/mdr.2017.0042

Therapeutic cefalexin use

Swine | Grower-finisher

1

Description

Cefalexin use broken up by treatment group

Resistance Outcomes

Resistance Microbe Outcome
Cefalexin
/
Escherichia coli
See: Figure 2 AMR+ (%) AMR- (%) Total (n)
Therapeutic AMU 8.60 70
No AMU 0.00 67